Is phosphatemia the best tool to monitor renal tenofovir toxicity?
Essig
Marie
M
Duval
Xavier
X
Kaied
Firas Al
FA
Iordache
Laura
L
Gervais
Anne
A
Longuet
Pascale
P
Blanchet
Francoise
F
Peytavin
Gilles
G
Leport
Catherine
C
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D005919:Glomerular Filtration Rate / Q000187:drug effects; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D007684:Kidney Tubules / Q000378:metabolism / Q000503:physiopathology; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D010710:Phosphates / Q000097:blood* / Q000378:metabolism; D000068698:Tenofovir
D015415:Biomarkers; D063065:Organophosphonates; D010710:Phosphates; D000068698:Tenofovir; D003404:Creatinine; D000225:Adenine